What's new

Human medicines European public assessment report (EPAR): Tysabri, natalizumab, Date of authorisation: 27/06/2006, Revision: 47, Status: Authorised

Human medicines European public assessment report (EPAR): Tysabri, natalizumab, Date of authorisation: 27/06/2006, Revision: 47, Status: Authorised

Apr 23, 2025 - 13:51
 0
Human medicines European public assessment report (EPAR): Tysabri, natalizumab, Date of authorisation: 27/06/2006, Revision: 47, Status: Authorised
Human medicines European public assessment report (EPAR): Tysabri, natalizumab, Date of authorisation: 27/06/2006, Revision: 47, Status: Authorised
Read More

Tags:

Previous Article

APT & Travelmarvel welcomes MS Estrela to Douro River

Next Article

Lockheed Martin Plans ‘Supercharged’ F-35 to Compete Against Boeing F-47

Related Posts

Human medicines European public assessment report (EPAR): Cimzia, certolizumab pegol, Date of authorisation: 01/10/2009, Revision: 37, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 5, 2025  0

EU Innovation Network (EU-IN)

EU Innovation Network (EU-IN)

Feb 13, 2025  0

Veterinary medicines European public assessment report (EPAR): Porcilis PCV, adjuvanted inactivated vaccine against porcine circovirus, Status: Authorised

Veterinary medicines European public assessment report ...

Mar 14, 2025  0